Status:
UNKNOWN
One-layer Versus Two-layer Duct-to-mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy .
Lead Sponsor:
Assiut University
Conditions:
Pancreatic Fistula
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Postoperative pancreatic fistula (POPF) is one of the most frequent and ominous complications after PD, and its occurrence reportedly ranges from 2-40 %. Severe POPF prolongs hospital stay and require...
Detailed Description
To date, pancreaticoduodenectomy (PD) has been regarded as the only potentially curative treatment for pancreatic head and periampullary tumors, including tumors in the ampullary region, distal biliar...
Eligibility Criteria
Inclusion
- Both male and female, aged 18 to 65. Patients scheduled to undergo pancreaticoduodenectomy.
Exclusion
- ; Patients who had a previous pancreatic operation; Patients with an immunodeficiency.
Key Trial Info
Start Date :
May 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05387538
Start Date
May 30 2022
End Date
August 1 2024
Last Update
May 27 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.